163 related articles for article (PubMed ID: 37045786)
1. Tumor Promoting Role of NRIP1 in Oral Squamous Cell Carcinoma: The Involvement of NSD2-Mediated Histone Methylation of DGCR8.
Zhang L; Hu G
Tohoku J Exp Med; 2023 Jul; 260(3):193-204. PubMed ID: 37045786
[TBL] [Abstract][Full Text] [Related]
2. NSD2 activates the E2F transcription factor 1/Y-box binding protein 2 axis to promote the malignant development of oral squamous cell carcinoma.
Zhang L; Hu G
Arch Oral Biol; 2022 Jun; 138():105412. PubMed ID: 35364436
[TBL] [Abstract][Full Text] [Related]
3. LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect malignant development of oral squamous cell carcinoma.
Dong C; Zhao Y; Yang S; Jiao X
J Oral Pathol Med; 2023 Jul; 52(6):493-503. PubMed ID: 36856154
[TBL] [Abstract][Full Text] [Related]
4. Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis.
Li S; Shi Z; Fu S; Li Q; Li B; Sang L; Wu D
Bioengineered; 2021 Dec; 12(1):7188-7204. PubMed ID: 34546854
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
[TBL] [Abstract][Full Text] [Related]
6. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
Wang C; Wang Q; Weng Z
Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069
[TBL] [Abstract][Full Text] [Related]
7. Splice site m
Li X; Fang J; Tao X; Xia J; Cheng B; Wang Y
PeerJ; 2023; 11():e14824. PubMed ID: 36811004
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
9. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
Rong L; Chen B; Liu K; Liu B; He X; Liu J; Li J; He M; Zhu L; Liu K; Shi X; Shuai Y; Jin L
J Transl Med; 2022 Apr; 20(1):148. PubMed ID: 35365168
[TBL] [Abstract][Full Text] [Related]
10. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
11. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
12. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circFOXO3 regulates KDM2A by targeting miR-214 to promote tumor growth and metastasis in oral squamous cell carcinoma.
Ai Y; Wu S; Zou C; Wei H
J Cell Mol Med; 2022 Mar; 26(6):1842-1852. PubMed ID: 34117688
[TBL] [Abstract][Full Text] [Related]
14. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
15. SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral squamous cell carcinoma.
Qiao C; Qiao T; Yang S; Liu L; Zheng M
Cancer Gene Ther; 2022 Jan; 29(1):122-132. PubMed ID: 33531646
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DLEU1 facilitates the progression of oral squamous cell carcinoma by miR-126-5p/GAB1 axis.
Sun KD; Ni YJ; Qin H; Xu QF
Kaohsiung J Med Sci; 2022 Oct; 38(10):950-959. PubMed ID: 36039933
[TBL] [Abstract][Full Text] [Related]
17. DDX27 regulates oral squamous cell carcinoma development through targeting CSE1L.
Li G; Li R; Wang W; Sun M; Wang X
Life Sci; 2024 Mar; 340():122479. PubMed ID: 38301874
[TBL] [Abstract][Full Text] [Related]
18. SET protein modulates H4 histone methylation status and regulates miR-137 level in oral squamous cell carcinoma.
Sousa LO; Sobral LM; de Almeida LO; Garcia CB; Greene LJ; Leopoldino AM
Epigenomics; 2020 Mar; 12(6):475-485. PubMed ID: 32267167
[No Abstract] [Full Text] [Related]
19. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00152 promotes oral squamous cell carcinoma growth via enhancing Upstream Transcription Factor 1 mediated Mitochondrial Ribosomal Protein L52 transcription.
Zou X; Hu X; He F; Zhang M; Kong X; Rui S; Liu Y; Wang L; Zheng X; Liu J; Li Z; Luo H
J Oral Pathol Med; 2022 May; 51(5):454-463. PubMed ID: 34664331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
